183 related articles for article (PubMed ID: 36167867)
1. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
[TBL] [Abstract][Full Text] [Related]
2. Analysis of sex-based differences in clinical and molecular responses to ischemia reperfusion after lung transplantation.
Chacon-Alberty L; Ye S; Daoud D; Frankel WC; Virk H; Mase J; Hochman-Mendez C; Li M; Sampaio LC; Taylor DA; Loor G
Respir Res; 2021 Dec; 22(1):318. PubMed ID: 34937545
[TBL] [Abstract][Full Text] [Related]
3. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
[TBL] [Abstract][Full Text] [Related]
4. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.
Cantu E; Suzuki Y; Diamond JM; Ellis J; Tiwari J; Beduhn B; Nellen JR; Shah R; Meyer NJ; Lederer DJ; Kawut SM; Palmer SM; Snyder LD; Hartwig MG; Lama VN; Bhorade S; Crespo M; Demissie E; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Wilkes D; Roe D; Ware LB; Wang F; Feng R; Christie JD;
Am J Transplant; 2016 Mar; 16(3):833-40. PubMed ID: 26663441
[TBL] [Abstract][Full Text] [Related]
5. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.
Hamilton BCS; Dincheva GR; Zhuo H; Golden JA; Brzezinski M; Singer JP; Matthay MA; Kukreja J
Clin Transplant; 2018 Apr; 32(4):e13210. PubMed ID: 29377268
[TBL] [Abstract][Full Text] [Related]
6. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation.
Hoffman SA; Wang L; Shah CV; Ahya VN; Pochettino A; Olthoff K; Shaked A; Wille K; Lama VN; Milstone A; Ware LB; Orens J; Weinacker A; Demissie E; Bellamy S; Kawut SM; Hancock WW; Christie JD;
Am J Transplant; 2009 Feb; 9(2):389-96. PubMed ID: 19120076
[TBL] [Abstract][Full Text] [Related]
7. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.
Shah RJ; Bellamy SL; Localio AR; Wickersham N; Diamond JM; Weinacker A; Lama VN; Bhorade S; Belperio JA; Crespo M; Demissie E; Kawut SM; Wille KM; Lederer DJ; Lee JC; Palmer SM; Orens J; Reynolds J; Shah A; Wilkes DS; Ware LB; Christie JD
J Heart Lung Transplant; 2012 Sep; 31(9):942-9. PubMed ID: 22694851
[TBL] [Abstract][Full Text] [Related]
8. Construct validity of the definition of primary graft dysfunction after lung transplantation.
Christie JD; Bellamy S; Ware LB; Lederer D; Hadjiliadis D; Lee J; Robinson N; Localio AR; Wille K; Lama V; Palmer S; Orens J; Weinacker A; Crespo M; Demissie E; Kimmel SE; Kawut SM
J Heart Lung Transplant; 2010 Nov; 29(11):1231-9. PubMed ID: 20655249
[TBL] [Abstract][Full Text] [Related]
9. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.
Prekker ME; Nath DS; Walker AR; Johnson AC; Hertz MI; Herrington CS; Radosevich DM; Dahlberg PS
J Heart Lung Transplant; 2006 Apr; 25(4):371-8. PubMed ID: 16563963
[TBL] [Abstract][Full Text] [Related]
10. Early protein expression profile in bronchoalveolar lavage fluid and clinical outcomes in primary graft dysfunction after lung transplantation.
Frick AE; Verleden SE; Ordies S; Sacreas A; Vos R; Verleden GM; Vanaudenaerde BM; Claes S; Schols D; Van Raemdonck DE; Neyrinck AP
Eur J Cardiothorac Surg; 2020 Aug; 58(2):379-388. PubMed ID: 32267918
[TBL] [Abstract][Full Text] [Related]
11. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Shah P; Arcasoy S; Wilkes DS; Christie JD; Ware LB;
Am J Transplant; 2014 Feb; 14(2):446-52. PubMed ID: 24400993
[TBL] [Abstract][Full Text] [Related]
12. Clinical risk factors for primary graft dysfunction in a low-volume lung transplantation center.
Nosotti M; Palleschi A; Rosso L; Tosi D; Mendogni P; Righi I; Montoli M; Crotti S; Russo R
Transplant Proc; 2014 Sep; 46(7):2329-33. PubMed ID: 25242781
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
[TBL] [Abstract][Full Text] [Related]
14. Ventilation parameters and early graft function in double lung transplantation.
Schwarz S; Benazzo A; Dunkler D; Muckenhuber M; Sorbo LD; Di Nardo M; Sinn K; Moser B; Matilla JR; Lang G; Taghavi S; Vamos FR; Jaksch P; Cypel M; Keshavjee S; Klepetko W; Hoetzenecker K
J Heart Lung Transplant; 2021 Jan; 40(1):4-11. PubMed ID: 33144029
[TBL] [Abstract][Full Text] [Related]
15. Correlation between Neutrophil Extracellular Traps (NETs) Expression and Primary Graft Dysfunction Following Human Lung Transplantation.
Bonneau S; Landry C; Bégin S; Adam D; Villeneuve L; Clavet-Lanthier MÉ; Dasilva A; Charles E; Dumont BL; Neagoe PE; Brochiero E; Menaouar A; Nasir B; Stevens LM; Ferraro P; Noiseux N; Sirois MG
Cells; 2022 Oct; 11(21):. PubMed ID: 36359815
[TBL] [Abstract][Full Text] [Related]
16. Impact of anastomosis time during lung transplantation on primary graft dysfunction.
Vandervelde CM; Vos R; Vanluyten C; Fieuws S; Verleden SE; Van Slambrouck J; De Leyn P; Coosemans W; Nafteux P; Decaluwé H; Van Veer H; Depypere L; Dauwe DF; De Troy E; Ingels CM; Neyrinck AP; Jochmans I; Vanaudenaerde BM; Godinas L; Verleden GM; Van Raemdonck DE; Ceulemans LJ
Am J Transplant; 2022 May; 22(5):1418-1429. PubMed ID: 35029023
[TBL] [Abstract][Full Text] [Related]
17. Increased Extravascular Lung Water and Plasma Biomarkers of Acute Lung Injury Precede Oxygenation Impairment in Primary Graft Dysfunction After Lung Transplantation.
Pottecher J; Roche AC; Dégot T; Helms O; Hentz JG; Schmitt JP; Falcoz PE; Santelmo N; Levy F; Collange O; Uring-Lambert B; Bahram S; Schaeffer M; Meyer N; Geny B; Lassalle P; Diemunsch P; Massard G; Kessler R; Steib A;
Transplantation; 2017 Jan; 101(1):112-121. PubMed ID: 27495752
[TBL] [Abstract][Full Text] [Related]
18. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
[TBL] [Abstract][Full Text] [Related]
19. Lung size mismatch and primary graft dysfunction after bilateral lung transplantation.
Eberlein M; Reed RM; Bolukbas S; Diamond JM; Wille KM; Orens JB; Brower RG; Christie JD;
J Heart Lung Transplant; 2015 Feb; 34(2):233-40. PubMed ID: 25447586
[TBL] [Abstract][Full Text] [Related]
20. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
